Carlton, Jill http://orcid.org/0000-0002-9373-7663
Powell, Philip A. http://orcid.org/0000-0003-1169-3431
Broadley, Melanie http://orcid.org/0000-0003-4408-6304
de Galan, Bastiaan E. http://orcid.org/0000-0002-1255-7741
Heller, Simon http://orcid.org/0000-0002-2425-9565
Comins, Jonathan http://orcid.org/0000-0002-8284-114X
Rosilio, Myriam http://orcid.org/0000-0003-0296-9061
Pouwer, Frans http://orcid.org/0000-0002-8172-9818
Gall, Mari-Anne http://orcid.org/0000-0001-7149-0092
Child, Christopher J. http://orcid.org/0000-0002-6195-2780
McCrimmon, Rory J. http://orcid.org/0000-0002-3957-1981
Rowen, Donna http://orcid.org/0000-0003-3018-5109
Funding for this research was provided by:
e Innovative Medicines Initiative 2 Joint Undertaking (777460)
Article History
Received: 5 December 2023
Accepted: 15 April 2024
First Online: 22 May 2024
Acknowledgements
: We would like to express our gratitude to the following: all members of the Hypo-RESOLVE PAC, including M. Hamid, S. O’Neill and K. Tait; C. Blome (University Medical Center Hamburg-Eppendorf, Germany) and A.-L. Newi (University Medical Center Hamburg-Eppendorf, Germany) who contributed to the cognitive debriefing work; J. Speight (Deakin University, Australia; The Australian Centre for Behavioural Research in Diabetes, Australia) who provided scientific advice throughout; and J. Brazier (University of Sheffield, UK) who retired mid-project. We would like to thank all those who participated in the research.
: All data generated or analysed during this study are included in the published article and its online supplementary files ().
: This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 777460. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and T1DExchange, JDRF, IDF, HCT. JCa, PAP, MB, BEdG, SH, FP, RJM and DR received funding for the project (payment to respective Institutions) as part of the Hypo-RESOLVE Consortium. The authors are solely responsible for the content of this work, which reflects only the authors’ views, and the JU is not responsible for any use that may be made of the information it contains.
: BEdG is a member of the Diabetologia Editorial Board. SH has received consulting fees from Eli Lilly (payment to International Hypoglycaemia Study Group), consulting fees from Zealand Pharma (payment to Institution), consulting fees from Zucara Pharma (payment to Institution), consulting fees from Novo Nordisk as part of Member of International Review Board (payment to Institution) and payment for expert testimony from patent case (personal payment); has participated on a Data Safety Monitoring Board or Advisory Board at Eli Lilly (payment to Institution) and is Chair of International Hypoglycaemia Study Group. JCo is an employee at Novo Nordisk. MR has stock or stock options at, and is an employee of, Eli Lilly and Company. M-AG is a shareholder and employee of Novo Nordisk. CJC holds stock or stock options at, and is an employee of Eli Lilly and Company. RJM has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Sanofi. DR is a member of the Euroqol Group; SF-6Dv2 licensing royalties.
: JCa, PAP, MB, BEdG, SH, JCo, MR, FP, M-AG, CJC and RJM contributed to the conceptualisation of the study. JCa and PAP curated the data, conducted formal analysis, developed study resources, led visualisation and wrote the original draft manuscript. JCa, PAP and DR planned and conducted the study investigation and validation. JCa, SH, MR, FP and RJM contributed to funding acquisition. JCa, PAP and MB contributed to study methodology. JCa, PAP and SH were involved in project administration. PAP developed study software. JCa, PAP, BEdG and SH were involved in study supervision. All authors were involved in reviewing and editing the draft manuscript. All authors approved the final version of the manuscript. JCa is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.